Personalized Cancer Vaccine Shows Long-Term Promise for High-Risk Melanoma Patients

In this episode, we explore promising new research on a personalized cancer vaccine that may help reduce cancer recurrence and improve long-term survival for patients with high-risk melanoma. You’ll learn: • What a personalized cancer vaccine is and how mRNA technology is being used in cancer treatment • Key findings from the Phase 2b KEYNOTE-942 melanoma trial • How the vaccine reduced the risk of distant cancer spread by 59% and recurrence or death by 49% • Why combining a personalized vacc...